Market Tracker

05/22 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

12.85
Delayed Data
As of May 22
 +0.10 / +0.78%
Today’s Change
6.08
Today|||52-Week Range
25.60
-19.89%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close12.75
Today’s open12.74
Day’s range12.66 - 13.01
Volume159,707
Average volume (3 months)579,795
Market cap$655.6M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+15.64%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book4.76

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.13+0.89%
SUPNSupernus Pharmaceuti...+0.18+1.36%
DVAXDynavax Technologies...-0.24-1.09%
INFIInfinity Pharmaceuti...-0.02-0.16%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Kleanthis G. Xanthopoulos
Vice President-Finance &
Accounting
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts